BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28900035)

  • 1. Prion protein is required for tumor necrosis factor α (TNFα)-triggered nuclear factor κB (NF-κB) signaling and cytokine production.
    Wu GR; Mu TC; Gao ZX; Wang J; Sy MS; Li CY
    J Biol Chem; 2017 Nov; 292(46):18747-18759. PubMed ID: 28900035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells.
    Liu S; Lv J; Han L; Ichikawa T; Wang W; Li S; Wang XL; Tang D; Cui T
    Biochem Biophys Res Commun; 2012 Mar; 420(1):78-83. PubMed ID: 22406061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-κB activation.
    Nagabhushana A; Bansal M; Swarup G
    PLoS One; 2011 Mar; 6(3):e17477. PubMed ID: 21408173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Necrosis Factor α Reduces SNAP29 Dependent Autolysosome Formation to Increase Prion Protein Level and Promote Tumor Cell Migration.
    Li H; Wang R; Yu Z; Shi R; Zhang J; Gao S; Shao M; Cui S; Gao Z; Xu J; Sy MS; Li C
    Virol Sin; 2021 Jun; 36(3):458-475. PubMed ID: 33237393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYLD deubiquitinates RIP1 in the TNFα-induced necrosome to facilitate kinase activation and programmed necrosis.
    Moquin DM; McQuade T; Chan FK
    PLoS One; 2013; 8(10):e76841. PubMed ID: 24098568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-Binding Function of RNA-Dependent Protein Kinase Promotes Proliferation through TRAF2/RIP1/NF-κB/c-Myc Pathway in Pancreatic β cells.
    Gao L; Tang W; Ding Z; Wang D; Qi X; Wu H; Guo J
    Mol Med; 2015 Feb; 21(1):154-66. PubMed ID: 25715336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding CYLD protein in NF-κβ/TNF-α signaling pathway in response to Lactobacillus acidophilus in non-metastatic rectal cancer patients.
    Zamani F; Khalighfard S; Kalhori MR; Poorkhani A; Amiriani T; Hosseinzadeh P; Esmati E; Alemrajabi M; Nikoofar A; Safarnezhad Tameshkel F; Alizadeh AM
    Med Oncol; 2023 Sep; 40(10):302. PubMed ID: 37725175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
    Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
    Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
    Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
    J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spermidine activates RIP1 deubiquitination to inhibit TNF-α-induced NF-κB/p65 signaling pathway in osteoarthritis.
    Chen Z; Lin CX; Song B; Li CC; Qiu JX; Li SX; Lin SP; Luo WQ; Fu Y; Fang GB; Wei-Ping L; Saw PE; Ding Y
    Cell Death Dis; 2020 Jul; 11(7):503. PubMed ID: 32632306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.
    Jono H; Lim JH; Chen LF; Xu H; Trompouki E; Pan ZK; Mosialos G; Li JD
    J Biol Chem; 2004 Aug; 279(35):36171-4. PubMed ID: 15226292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-associated domain-containing ubiquitin regulatory X (UBX) protein UBXN1 is a negative regulator of nuclear factor κB (NF-κB) signaling.
    Wang YB; Tan B; Mu R; Chang Y; Wu M; Tu HQ; Zhang YC; Guo SS; Qin XH; Li T; Li WH; Li AL; Zhang XM; Li HY
    J Biol Chem; 2015 Apr; 290(16):10395-405. PubMed ID: 25681446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration.
    Xiao N; Li H; Luo J; Wang R; Chen H; Chen J; Wang P
    Biochem J; 2012 Feb; 441(3):979-86. PubMed ID: 22029577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
    Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
    Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RING domain of TRAF2 plays an essential role in the inhibition of TNFalpha-induced cell death but not in the activation of NF-kappaB.
    Zhang L; Blackwell K; Shi Z; Habelhah H
    J Mol Biol; 2010 Feb; 396(3):528-39. PubMed ID: 20064526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-specific peptidase 21 inhibits tumor necrosis factor alpha-induced nuclear factor kappaB activation via binding to and deubiquitinating receptor-interacting protein 1.
    Xu G; Tan X; Wang H; Sun W; Shi Y; Burlingame S; Gu X; Cao G; Zhang T; Qin J; Yang J
    J Biol Chem; 2010 Jan; 285(2):969-78. PubMed ID: 19910467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy.
    Dhingra R; Rabinovich-Nikitin I; Rothman S; Guberman M; Gang H; Margulets V; Jassal DS; Alagarsamy KN; Dhingra S; Valenzuela Ripoll C; Billia F; Diwan A; Javaheri A; Kirshenbaum LA
    Circulation; 2022 Sep; 146(12):934-954. PubMed ID: 35983756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.
    Park ES; Choi S; Shin B; Yu J; Yu J; Hwang JM; Yun H; Chung YH; Choi JS; Choi Y; Rho J
    J Biol Chem; 2015 Apr; 290(15):9660-73. PubMed ID: 25716317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of JNK signaling by the tumor suppressor CYLD.
    Reiley W; Zhang M; Sun SC
    J Biol Chem; 2004 Dec; 279(53):55161-7. PubMed ID: 15496400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.